A hormonal condition that affects millions of women worldwide has just been given a new name. As of May 12, 2026, polycystic ovary syndrome (PCOS) is now officially called polyendocrine metabolic ovarian syndrome, or PMOS.
This is not just a terminology update. It is a correction that has been a long time coming.
The Numbers Tell You How Serious This Is: PCOS Statistics
- The global incidence of PCOS increased from 1.48 million cases in 1990 to 2.3 million in 2021, and these numbers are expected to cross even higher numbers in 2026.
- Today, PMOS affects 1 in 8 women globally. That is over 170 million women.
- According to the World Health Organization, up to 70% of those affected do not even know they have it.
- In India, the picture is just as worrying. A 2022 meta-analysis found that the pooled prevalence of PCOS in Indian women is around 11.33%.
- India has seen approximately a 30% rise in PCOS prevalence in recent years and ranks among the top five countries in the world for incident cases.
- Among Indian adolescent girls, the numbers are even higher. Approximately 1 in 5 Indian adolescent girls may have the condition.
The Wrong Name Was Causing Real Harm
The old name, PCOS, pointed to cysts on the ovaries. But that description was never accurate.
According to The Lancet, the term PCOS was inaccurate and referred only to ovarian cysts. However, the condition is mainly a hormonal and metabolic disorder. This misunderstanding often led to delayed diagnosis, fragmented care, and stigma around the condition.
Women were coming to doctors with real symptoms and leaving without answers. The name itself was steering the conversation in the wrong direction.
A complex hormonal disorder was being reduced to a problem of the ovaries, and that framing had consequences for how doctors tested, treated, and understood these patients.
What the New Name of PCOS Actually Means
Polyendocrine metabolic ovarian syndrome, PMOS, the new name of PCOS, reflects what the condition actually is.
- The word “polyendocrine” tells you this involves multiple hormones across different systems in the body.
- “Metabolic” points to how it affects weight, blood sugar, and insulin.
Together, the name makes clear this is a whole-body condition, not just a reproductive one.
The new name, PMOS, recognizes that this is a complex, multisystem condition involving endocrine, metabolic, reproductive, dermatological, and psychological health.
14 Years, 14,360 Surveys, One Change
This did not happen overnight. The implication involved people from the whole world, including doctors, researchers, patients, and charities, who shared their views on what the new name should accomplish.
- The process involved collaboration across 56 leading academic, clinical, and patient organizations.
- Along with over 14,360 survey responses from patients and health professionals across multiple world regions.
- With around 90 representatives, agreed principles were generated.
What Stays the Same
For people already diagnosed with PCOS, treatment and care will stay the same. However, changes will happen in medical guidelines, doctor training, and global disease classification systems. This will help the new name and understanding of the condition be used consistently around the world.
A better name means better understanding. And for millions of women who were misdiagnosed or ignored for years, this understanding has come much later than it should have.
References
The Lancet | WHO Fact Sheet | PMC – India Prevalence Meta-Analysis | PMC – India Rise & Burden | PMC – Indian Adolescent Prevalence
Post Comment